Are you Dr. Liljenquist?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 108 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3910 Washington Pkwy
Idaho Falls, ID 83404Phone+1 208-523-1122Fax+1 208-523-2582- Is this information wrong?
Summary
- Dr. David Liljenquist, MD is an endocrinologist in Idaho Falls, Idaho. He is currently licensed to practice medicine in Idaho, Illinois, and Arizona. He is affiliated with Eastern Idaho Regional Medical Center and Mountain View Hospital.
Education & Training
University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2005
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2000 - 2003
George Washington University School of Medicine and Health SciencesClass of 2000
Certifications & Licensure
ID State Medical License 2005 - 2025
IL State Medical License 2003 - 2005
AZ State Medical License 2001 - 2005- National Board of Physicians and Surgeons Endocrinology Diabetes and Metabolism
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2011, 2013
Clinical Trials
- Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Start of enrollment: 2011 Apr 01
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2014 Feb 01
- Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsAccuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System.Shridhara Alva, Ronald Brazg, Kristin Castorino, Mark Kipnes, David R Liljenquist, Hanqing Liu> ;Diabetes Therapy. 2023 Apr 1
- 32 citationsGlycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial.Gregory P Forlenza, Laya Ekhlaspour, Linda A DiMeglio, Larry A Fox, Henry Rodriguez, Dorothy I Shulman, Kevin B Kaiserman, David R Liljenquist, John Shin, Scott W Lee,...> ;Pediatric Diabetes. 2022 May 1
- 53 citationsAccuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes.Shridhara Alva, Timothy L. Bailey, Ronald L. Brazg, Erwin S. Budiman, Kristin Castorino, Mark P. Christiansen, Gregory P. Forlenza, Mark Kipnes, David R Liljenquist, H...> ;Journal of Diabetes Science and Technology. 2020 Sep 19
- Join now to see all
Authored Content
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults with Type 1 DiabetesJune 2020
Professional Memberships
- Member
Hospital Affiliations
- Eastern Idaho Regional Medical CenterIdaho Falls, Idaho
Mountain View HospitalIdaho Falls, Idaho
